Hōʻike ka noiʻi hiki ke hoʻohana ʻia ʻo PixCell's HemoScreen™ e nānā i nā hōʻailona koko pathological a hoʻomaikaʻi i ke kaʻina hana o nā maʻi me nā maʻi koko.
ILIT, York, ʻIseraʻela, ʻOkakopa 13, 2020 /PRNewswire/ - PixCell Medical, ka mea hoʻomohala o nā hoʻonā diagnostic wikiwiki, i kēia lā ua hoʻolaha i nā hopena o kahi noiʻi hou i paʻi ʻia ma ka International Journal of Laboratory Hematology Ma muli o ka hopena, hōʻike ka haʻawina ʻO ka HemoScreen™ kahi mea nānā koko ʻaoʻao moe he kūpono no ka loiloi a me ka hoʻokele ʻana i nā poʻe maʻi maʻi maʻi koko e mālama ana i ka mālama ʻana i ka chemotherapy.
Ua hoʻohālikelike nā mea noiʻi mai ka Halemai o North New Zealand, ke Kulanui o Copenhagen, nā Halemai Bispebjerg a me Frederiksberg ma Copenhagen, a me ke Kulanui o Southern Denmark iā HemoScreen™ a me Sysmex XN-9000 i 206 mau hōʻailona vein maʻamau a me 79 keʻokeʻo keʻokeʻo (WBC) ʻaoʻao capillary moena. laʻana , Helu neutrophil piha (ANC), ke koko ʻulaʻula (RBC), helu platelet (PLT) a me ka hemoglobin (HGB).
"ʻO nā poʻe maʻi maʻi maʻi maʻi maʻi maʻi maʻi maʻi maʻi maʻi maʻi pinepine i ka hoʻopau ʻana i ka iwi iwi ma muli o ka mālama ʻana a koi i ka nānā mau ʻana i nā helu koko piha (CBC)," wahi a Kauka Avishay Bransky, Luna Nui o PixCell Medical."Ke hōʻike nei kēia haʻawina hiki iā HemoScreen ke hāʻawi i nā hopena wikiwiki a hilinaʻi hoʻi no nā laʻana maʻamau a me nā laʻana pathological.Hiki i ka hoʻohana nui ʻana i kēia hāmeʻa ke hoʻopau i nā kipa halemai pili ʻole a hoʻopōkole loa i ka manawa kūkākūkā kūpono-no ka poʻe i loaʻa i ka maʻi a me ka luhi.No nā poʻe maʻi, he pāʻani hoʻololi pāʻani kēia. "
Hōʻike ka ʻikepili e hoʻohana ana ʻo HemoScreen i 40 μl o ke koko venous a i ʻole capillary a me nā haʻahaʻa haʻahaʻa o WBC, ANC, RBC, PLT a me HGB e hāʻawi i nā hopena hoʻokolohua wikiwiki a hilinaʻi hoʻi no ke alakaʻi ʻana i ke kahe koko a me ka mālama ʻana ma hope o ka chemotherapy.Ua ʻike pū ka hui noiʻi ua lawa ka maʻalahi o HemoScreen i ka hōʻailona ʻana i nā laʻana pathological a me nā cell abnormal (me nā sela koko ʻulaʻula nucleated, granulocytes ʻaʻole, a me nā cell primitive), a hoʻemi nui i ka manawa huli o nā hopena hōʻike.
ʻO HemoScreen™, i hoʻomohala ʻia e PixCell Medical, ʻo ia wale nō ka mea nānā hematology i ʻae ʻia e ka FDA, i hoʻolālā ʻia no ka point-of-care (POC), e hui pū ana i ka cytometry kahe a me ke kiʻi kiʻi kiʻi ma kahi kahua hoʻokahi.Hiki i ka mīkini hoʻopaʻa hematology compact portable ke hoʻopau i ka hoʻāʻo ʻana i ka helu koko piha (CBC) i loko o 6 mau minuke, a hoʻohana i kahi pahu hoʻolele hoʻolele i hoʻopiha mua ʻia me nā reagents pono āpau no nā hoʻokolohua wikiwiki, pololei a maʻalahi.
Ua hoʻoholo ka haʻawina he kūpono loa ʻo HemoScreen no nā keʻena maʻi maʻi liʻiliʻi a kūpono paha no ka hoʻohana ʻana i ka home.
Hāʻawi ʻo PixCell Medical i ka hoʻonā koko koko hikiwawe mua loa.Me ka hoʻohana ʻana i ka ʻenehana hoʻokele viscoelastic i hoʻopaʻa ʻia a me ka ʻike mīkini ʻike artificial, ʻo PixCell's FDA-approved a me CE-approved HemoScreen diagnostic platform e hōʻemi i ka manawa hāʻawi o nā hopena diagnostic mai kekahi mau lā a i kekahi mau minuke.Me kahi kulu koko wale nō, hiki iā PixCell ke hāʻawi i nā heluhelu pololei o 20 mau helu helu koko maʻamau i loko o ʻeono mau minuke, e mālama ai i nā maʻi, nā kauka a me nā ʻōnaehana olakino i ka manawa a me ke kumukūʻai.
Ka manawa hoʻouna: Iulai-15-2021